Tech Company Financing Transactions
Rodeo Therapeutics Funding Round
Rodeo Therapeutics, based in Seattle, raised $5.4 million in funding from private investors.
Transaction Overview
Company Name
Announced On
8/3/2017
Transaction Type
Venture Equity
Amount
$5,354,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2815 Eastlake Ave. E 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Overview
Rodeo Therapeutics is focused on developing small-molecule therapies that increase tissue levels of prostaglandin PGE2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Stanton Gerson
Founder
Sanford Markowitz
Founder
Joseph Ready
Browse more venture capital transactions:
Prev: 8/3/2017: Atlas Obscura venture capital transaction
Next: 8/3/2017: Eloxx Pharma venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs